![](/img/cover-not-exists.png)
PCV2 COST-EFFECTIVENESS OF AN INTENSIVE TREATMENT WITH 80MGATORVASTATINVS 40 MG PRAVASTATIN IN ACUTE CORONARY SYNDROME: AN ECONOMIC EVALUATION BASED ON THE PROVE-IT (PRAVASTATIN ORATORVASTATIN EVALUATION AND INFECTION THERAPY)
J F Bobadilla, M GarciaVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67414-1
File:
PDF, 63 KB
english, 2005